Biomedical Chromatography 1989-03-01

HPLC method for simultaneous determination of clobazam and N-desmethylclobazam in human serum, rat serum and rat brain homogenates.

W R Gaździk, J Podleśny, M Filipek

Index: Biomed. Chromatogr. 3(2) , 79-81, (1989)

Full Text: HTML

Abstract

A method for simultaneous determination of clobazam (CBZ) and its active metabolite N-desmethylclobazam (DCBZ) in various biological samples by RP-HPLC with UV detection is described. The determination of both CBZ and DCBZ is performed without derivatization. The internal standard is diazepam. The method is rapid and simple with sensitivity limits of 10 ng/mL for both CBZ and DCBZ and is suitable for routine analysis as well as for animal studies.

Related Compounds

  • N-Desmethyl Cloba...

Related Articles:

Blood concentrations of clobazam and norclobazam in a lethal case involving clobazam, meprobamate and clorazepate.

2010-11-01

[Leg. Med. (Tokyo.) 12(6) , 300-4, (2010)]

Simultaneous determination of clobazam and its major metabolite in human plasma by a rapid HPLC method.

2005-09-05

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 823(2) , 167-71, (2005)]

A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam.

2004-12-01

[Brain Dev. 26(8) , 530-4, (2004)]

Analysis of clobazam and its active metabolite norclobazam in plasma and serum using HPLC/DAD.

1996-11-01

[Scand. J. Clin. Lab. Invest. 56(7) , 609-14, (1996)]

Eye rolling as a manifestation of clobazam toxicity in a child with epilepsy.

2006-07-01

[Dev. Med. Child Neurol. 48(7) , 612-5, (2006)]

More Articles...